Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Open accessThe DOI matches its Crossref record; 319 of the 333 references it cites were found in a registry or an index.
Abstract
Human T lymphotropic viruses (HTLVs) are complex deltaretroviruses that do not contain a proto-oncogene in their genome, yet are capable of transforming primary T lymphocytes both in vitro and in vivo. There are four known strains of HTLV including HTLV type 1 (HTLV-1), HTLV-2, HTLV-3 and HTLV-4. HTLV-1 is primarily associated with adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-2 is rarely pathogenic and is sporadically associated with neurological disorders. There have been no diseases associated with HTLV-3 or HTLV-4 to date. Due to the difference in the disease manifestation between HTLV-1 and HTLV-2, a clear understanding of their individual pathobiologies and the role of various viral proteins in transformation should provide insights into better prognosis and prevention strategies. In this review, we aim to summarize the data accumulated so far in the transformation and pathogenesis of HTLV-1, focusing on the viral Tax and HBZ and citing appropriate comparisons to HTLV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Tomita, M., Semenza, G. L., Michiels, C., Matsuda, T., Uchihara, J., Okudaira, T., Tanaka, Y., Taira, N., Ohshiro, K., & Mori, N. (2007) · Biochemical Journal · doi:10.1042/bj20070286 · Cited by 51 · cited 2×
“Mechanistically, Tax frees a catalytic p110 subunit of the PI3K complex from an inhibitory p85 subunit by binding directly to the latter [256]; Tax induces the RelA-mediated sequestration of p300 from the promoters of phosphatase and tensin homolog (PTEN) and SH2 domain-containing inositol phosphatase - 1 (SHIP-1),…”
BackgroundRetractedHuman T-Cell Leukemia Virus Type 1 Tax Dysregulates β-CateninSignaling
Tomita, M., Kikuchi, A., Akiyama, T., Tanaka, Y., & Mori, N. (2006) · Journal of Virology · doi:10.1128/jvi.00739-06 · Cited by 36
RetractedFukuda, R.-I., Tsuchiya, K., Suzuki, K. A. O., Itoh, K., Fujita, J., Utsunomiya, A., & Tsuji, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806325200 · Cited by 21
RetractedPoiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043 · cited 2×
“HTLV-1 was originally identified in 1980 in a T cell line derived from a patient with cutaneous T cell lymphoma [1] and was also detected in adult T cell leukemia (ATL) patients [2,3].”
BackgroundPhosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766 · cited 1×
“enhancer [204,205,207].”
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588 · cited 2×
“(p50/p105) and NF-B2 (p52/p100) [204-206].”
BackgroundHTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,404 · cited 1×
“On the contrary, for HAM/TSP, disease progression can typically occur within a few years of infection [94,98].”
BackgroundIntegrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252
Research works printed but not linked: 2
- Matsumoto, 1979, Adult T-cell leukemia-lymphoma in Kagoshima District, southwestern Japan: Clinical and hematological characteristics, Jpn. J. Clin. Oncol., 9, 325
- Murata, 1996, Prevention of HTLV-1 infection in Japanese macaques by passive immunization, Leukemia, 10, 1971
Cited by
Hijacking of the AP-1 Signaling Pathway during Development of ATL
Gazon, H., Barbeau, B., Mesnard, J.-M., & Peloponese, J.-M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02686 · Cited by 250
“A subset of HTLV-1-infected individuals will develop ATL after an extended period of time (Matsuoka and Jeang, 2007; Kannian and Green, 2011).”
BackgroundViral Oncology: Molecular Biology and Pathogenesis
Mui, U., Haley, C., & Tyring, S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6120111 · Cited by 222
Morales-Sánchez, A., & Fuentes-Pananá, E. (2014) · Viruses · doi:10.3390/v6104047 · Cited by 220
“(reviewed in [89]).”
The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral Infections
Vieira, V. C., & Soares, M. A. (2013) · BioMed Research International · doi:10.1155/2013/683095 · Cited by 139
Mechanisms of Oncogenesis by HTLV-1 Tax
Mohanty, S., & Harhaj, E. W. (2020) · Pathogens · doi:10.3390/pathogens9070543 · Cited by 131
Metadata
- Authors
- Kannian, P., & Green, P. L.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Green, Patrick L.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2010-09-24
- Volume
- 2
- Issue
- 9
- Pages
- 2037-2077
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC3185741
- OpenAlex
- W2040466820
- Cited by
- 139
- References
- 333
- Citations by year
- 2026: 9 · 2025: 1 · 2024: 9 · 2023: 15 · 2022: 9 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 9 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 9 · 2013: 10 · 2012: 12
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- HTLV-1, T-cell transformation, carcinogenesis, adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy/tropical spastic paraparesis, HTLV-II, viral pathogenesis, viral proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis. https://app.cochat.ai/papers/10.3390/v2092037
- The paper
- Kannian, P., & Green, P. L. (2010). Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis. Viruses. https://doi.org/10.3390/v2092037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.